News

The findings may enable better cancer treatments and new interventions for heart disease.

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

The strategy relies on natural cancer-targeting cells of the immune system, called natural killer cells, that have been modified to selectively target lymphoma cells.

A new tool enables scientists to tackle difficult molecular recognition problems to aid drug discovery for incurable diseases.

A pioneering chemist, Yu's research has paved the way to powerful new techniques used in fields ranging from drug discovery to materials science.

The discovery of abnormal chemical reactions may lead to novel targets for drugs that treat neurodegenerative diseases.

More consumers are turning to quick DNA tests to learn their disease risks, but the scores they receive aren't always as precise as they could be.

The researchers on the 2020 list rank in the top 1 percent of citations in their field over the prior decade, as measured by Web of Science, world’s largest publisher-neutral citation index.

Scientists developed an approach that successfully generates antibodies against numerous strains of the fast-evolving human immunodeficiency virus.

In their quest to understand how the immune system is implicated in alcohol use disorder, Scripps Research scientists have found a potential path for treatment. 

With funding from the Centers for Disease Control and Prevention, scientists at Scripps Research and UC San Diego are sequencing the virus to help guide local outbreak response.

A compound designed at Scripps Research works in early tests against myotonic dystrophy 1 and Fuchs endothelial corneal dystrophy, which together affect millions of people.

Sensor data from wearable devices can complement virus testing and conventional screening to signal new infections.

Scientists have uncovered a potential new approach for treating eye diseases that affect millions of people around the world. 

The Louise Hanson Marshall Award honors individuals who significantly promoted the professional development of women in neuroscience.

The monoclonal antibody treatment will be tested in clinical trials, with the goal of reaching patients around the world, including in low- and middle-income countries.    

In rodent experiments modeled to mimic real-life circumstances, scientists revealed brain mechanisms that could lead to targeted treatments. 

The technique should help in the design of vaccines against HIV, SARS-CoV-2 and other viruses that cloak their outer proteins with sugars to evade antibodies.

Leaders from area’s top biomedical research institutes unite in outlining potentially negative impact of proposal, if implemented, on international scholars and scientific progress.

The technique seeks to fill an unmet need among scientists and doctors who need faster, more precise tools to identify useful tumor-infiltrating immune cells.

Researchers harness information theory to better understand how to make complex and compact molecules resembling those in nature.

In studies involving roundworms, Scripps Research scientists discover a cellular process that may hold implications for treating metabolic diseases.

A gene associated with autism is found to direct the speed at which neurons mature.

A signaling system implicated in liver fibrosis and immune activation is better understood thanks to this creative chemical fishing lure.